Answers are grounded in this paper and cite their sources.
Background Asthma in children with sickle cell disease (SCD) may show functional characteristics that differ from asthma without SCD, but comparisons are vulnerable to differences in source-cohort ascertainment. We compared clinically available characteristics in children with asthma with and without SCD and explored the degree to which a restricted set of harmonized variables discriminated the two groups. Methods This secondary comparative analysis used two July 2026 analytic datasets from French Guiana. The non-SCD cohort included 180 children aged 5-17 years with physician-diagnosed asthma. The SCD source dataset contained 161 children who underwent respiratory assessment; 95 with an archived confirmed-asthma classification formed the SCD-asthma group. Primary analyses were restricted to variables measured comparably and completely in both groups: age, sex, health-insurance status, place of residence, and bronchodilator responsiveness (BDR; archived historical definition >12% FEV1 increase). Logistic regression adjusted for these covariates. Penalized logistic regression, random forest, and gradient boosting were evaluated by repeated stratified five-fold cross-validation (20 repeats). Results The final comparative cohort comprised 275 children (180 without SCD; 95 with SCD). Children with SCD and asthma were older (10.4 ± 3.3 vs. 9.2 ± 3.3 years; p = 0.003), more often had health-insurance coverage (88.4% vs. 66.1%; p < 0.001), and more often had recorded BDR (91.6% vs. 59.4%; p < 0.001). In adjusted analysis, BDR remained strongly associated with SCD-asthma group membership (aOR 7.58, 95% CI 3.34-17.22), as did age (aOR 1.14 per year, 95% CI 1.05-1.24) and insurance coverage (aOR 3.67, 95% CI 1.72-7.82). Model discrimination was moderate (AUC 0.762-0.768). Conclusion Children with asthma and SCD showed an overlapping rather than clearly separate profile, with greater recorded bronchodilator responsiveness and modest differences in age and healthcare-context variables. Because the source cohorts used different diagnostic pathways and the archived files lack raw pre/post-bronchodilator values and GLI z-scores, these findings should be interpreted as associations requiring prospective confirmation using harmonized contemporary respiratory criteria.
No takes yet. Share an insight, caveat, or question.
Bafunyembaka et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: